Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Steiner I, Holloway R, Thompson J, Noyes K, Dorsey E, Schwid S. QUANTITATIVE RISK-BENEFIT ANALYSIS OF NATALIZUMAB. Neurology 2009;72:1791-2; author reply 1791-2. [DOI: 10.1212/01.wnl.0000347020.85704.36] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open

For:	Steiner I, Holloway R, Thompson J, Noyes K, Dorsey E, Schwid S. QUANTITATIVE RISK-BENEFIT ANALYSIS OF NATALIZUMAB. Neurology 2009;72:1791-2; author reply 1791-2. [DOI: 10.1212/01.wnl.0000347020.85704.36] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open

Number

Cited by Other Article(s)

Steiner I, Schmutzhard E, Sellner J, Chaudhuri A, Kennedy PGE. EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol 2012;19:1278-91. [DOI: 10.1111/j.1468-1331.2012.03808.x] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2012] [Accepted: 06/12/2012] [Indexed: 11/30/2022]

Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiol Drug Saf 2009. [DOI: 10.1002/pds.1655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]